Viking Therapeutic (VKTX) PT Raised to $38 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Price: $26.83 -1.65%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
Truist Securities analyst Joon Lee raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $38.00 (from $32.00) while maintaining a Buy rating.
You May Also Be Interested In
- Viking Therapeutics (VKTX) call put ratio 4.1 calls to 1 put with a focus on October 30 weekly 25 and 30 calls
- Neogen Chemicals (NEOGEN:IN) PT Raised to INR2,260 at Kotak
- SEPLAT Petro (SEPL:LN) PT Raised to GBP9.60 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
